Hints and tips:
Related Special Reports
...Merck’s drug, which is branded Lagevrio, raised hopes and sent shares in the company rallying last year after early data from a late-stage trial suggested it cut in half the risk of death and hospitalisation...
...Dean Li, president of Merck’s research laboratories, praised the UK’s scientific talent and expertise, hoping that the investment in King’s Cross will help researchers at MSD, known as Merck in the US, work...
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
...But, of course, there’s a reason why it’s widely called Shitibank; the sprawling, gormless Citi has for a v v v very long time proven adept at blithely ambling onto various rakes around the world....
...Merck’s drug raised fresh hopes and sent shares in the company rallying late last year after early data from a late-stage trial suggested that it cut in half the risk of death and hospitalisation....
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...Merck’s lawsuit is the first by a major drug company, but analysts predict others are likely to follow its lead and sue the government ahead of the full implementation of the drug price negotiation elements...
...Yet Merck recorded sales worth more than $6bn between 2021 and 2022, and the figure does not include sales in poorer markets where licensed companies make generic versions of the drug....
...Merck’s market capitalisation is $300bn and it has more than $13bn in cash. Its shareholders understand that these gambles are required ahead of blockbuster drugs rolling off patent....
...Its companies have combined annual revenues of $75bn and 115,000 employees....
...Robert Davis, Merck’s chair and chief executive....
...the crisp company....
...Molnupiravir, the antiviral pill developed by Merck to treat Covid-19, speeded up patients’ recovery but failed to reduce risks of hospitalisation and death, full results of an extensive UK clinical trial...
...Eight of the nine companies are fighting the proposals at the Securities and Exchange Commission. Companies routinely challenge shareholder proposals at the SEC and often win....
...Merck was in talks last summer to acquire Seagen for about $200 a share, or $40bn. But negotiations ended after the two failed to agree on price....
...Weber is a paid consultant for Merck and Moderna....
...Merck had been in talks to acquire Seagen last summer, offering about $200 a share, according to people familiar with the matter....
...Campaigners are supported by more than 400 senior pharma and biotech executives at companies, including Pfizer and Merck, who have spoken out against a preliminary injunction against abortion pill mifepristone...
...Merck’s Keytruda now tackles 18 tumour types and is set to be the world’s top-selling medicine next year, according to Evaluate Vantage....
...Merck, Bristol Myers Squibb and Amgen have all used these aggressive tactics to protect blockbuster drugs from competition, said O’Reilly....
...Drugmaker Merck has defended the company’s approach to tax after a US congressional committee accused it of exploiting loopholes to avoid paying billions of dollars and blocking an inquiry into its practices...
...On paper, Merck’s interest in buying the cancer biotechnology company SeaGen for about $40bn makes plenty of sense. The US drugmaker is flush with cash — to the tune of $8.6bn at the end of March....
...And it takes time to change the culture,” said Funtleyder, whose fund owns shares in Merck and Lilly but not Pfizer....
...I think a lot of people were anticipating a V-shaped recovery . . . People are now waking up the realisation that volatility is going to be normal going forward.”...
International Edition